Instrument NameBiontech Se ADRInstrument Symbol(BNTX-Q)

Instrument ExchangeNASDAQ

The S&P 500 Index ($SPX ) (SPY ) Tuesday closed up +0.40%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.28%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.71%. Stocks on Tuesday recovered from early losses and settled mixed, with the Dow Jones...

The S&P 500 Index ($SPX ) (SPY ) today is down -0.05%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.41%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.11%. Stocks are mixed today, with the Dow Jones Industrials falling to a 1-1/2 week...

The S&P 500 Index ($SPX ) (SPY ) today is down -0.50%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.81%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.40%. Stocks are retreating today, with the Dow Jones Industrials falling to a 1-1/2 week...

The S&P 500 Index ($SPX ) (SPY ) Friday closed down -1.32%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.70%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -2.40%. Stocks retreated Friday, with the S&P 500 and Nasdaq 100 falling to 1-1/2 week...

The S&P 500 Index ($SPX ) (SPY ) today is down -1.17%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.72%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -2.03%. Stocks today extended Thursday’s decline, with the S&P 500 and the Dow Jones Industrials...

The S&P 500 Index ($SPX ) (SPY ) today is down -0.70%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.34%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -1.36%. Stocks today are adding to Thursday’s losses, with the S&P 500, the Dow Jones...

BNTX earnings call for the period ending September 30, 2024.

This drugmaker's lead candidate could become a top-selling cancer therapy.

Pfizer Inc. (NYSE: PFE) hit its peak during the COVID-19 pandemic when its vaccines developed with BioNTech SE (NASDAQ: BNTX) sent shares surging up to $61.71

/CNW/ - Pfizer Canada ULC and BioNTech SE (Nasdaq: BNTX, "BioNTech") announced today that Health Canada has authorized the KP.2 variant adapted COMIRNATY®...

Find out why positive results from a Summit Therapeutics study keep pushing up BioNTech and Instil Bio stock.

The biotech continues to earn important wins, but is it enough?

Issued on behalf of BioVaxys Technology Corp. VANCOUVER – USA News Group – Back in 2022, Nature published an article titled Cancer vaccines:...

A clinical-trial failure for Pfizer and BioNTech means Moderna is leading the race to develop a combo shot for the flu and COVID-19.

Investors were cautiously pessimistic about the latest news coming out of the company's lab.

BNTX earnings call for the period ending June 30, 2024.

BioNTech (BNTX), a prominent player in the biotechnology sector, has announced its financial results for the second quarter of 2024, showcasing a mix of significant achievements and challenges. This quarter has been pivotal for BioNTech as it continues to navigate the evolving landscape of the biotechnology industry. Key Insights from...

Even if you can see it coming, you’re never going to time it just right

USA News Group – Recognized as one of the most lethal cancers, researchers are striving to improve survival rates for pancreatic cancer patients by focusing on earlier detection. According to Johns Hopkins Medicine, up to 80% of patients are...

/CNW/ -- USA News Group – Recognized as one of the most lethal cancers, researchers are striving to improve survival rates for pancreatic cancer patients by...

USA News Group News Commentary – As the 2024 American Society of Clinical Oncology (ASCO) annual meeting approaches, excitement builds over the latest in cancer treatment advancements, particularly in Antibody-Drug Conjugates (ADCs). From...

A bird flu outbreak could spur demand for vaccines from these key players, but is it likely?

Moderna has been locked in a legal battle with Pfizer-BioNTech over their COVID shot Comirnaty after suing them in 2022 for allegedly copying its mRNA technology

BNTX earnings call for the period ending March 31, 2024.